INTRODUCTION
Although neurodegenerative disorders are mostly prevalent in the elderly, they also occur early in life. In infants and children, inborn errors of metabolism, in particular lysosomal storage diseases (LSDs), represent the most frequent cause of neurodegeneration. LSDs result from inefficient recycling of macromolecule catabolites, which accumulate and cause a multitude of clinical symptoms, including progressive mental retardation.
Whereas primary genetic and biochemical disorders are well described in LSDs, the limitations of currently available study models hampered accurate exploration of downstream cascades of events. Investigations in mouse models or in * To whom correspondence should be addressed at: Unité Rétrovirus et Transfert Génétique, INSERM U622, Département de Neuroscience, Institut Pasteur, 28 rue du Dr Roux, 75015 Paris, France. Tel: +33 145688412; Fax: +33 145688940; Email: delphine.bohl@pasteur.fr patient cell cultures identified disorders consistent with cell autonomous dysfunctions. They affect endocytosis (1, 2) , macro-autophagy (3), calcium homeostasis (4, 5) , mitochondria (6) , endoplasmic reticulum homeostasis (7, 8) , phospholipid synthesis (9, 10) , neurite outgrowth (5, 11) and neural stem cell production, migration and differentiation (12) . In the central nervous system (CNS), neural cell disorders are associated with neuroinflammation, which presumably aggravates neurodegeneration (13) . However, the relevance of cell disorders to the neurological manifestations observed in children remains unclear.
Mucopolysaccharidosis IIIB (MPSIIIB, Sanfilippo syndrome type B) is an LSD caused by a-N-acetylglucosaminidase (NAGLU, EC 3.2.1.50) deficiency, a lysosomal hydrolase involved in heparan sulfate (HS) proteoglycan degradation. Severe neurological manifestations contrast with mild expression of the disease in peripheral organs. The onset of behavioral changes is at 3 -5 years of age, followed by progressive mental retardation and premature death (14) . Patient autopsy revealed storage lesions in the CNS, macrophages, liver and kidney epithelial cells, but not in other tissues (15) (16) (17) . Similar pathology was observed in the mouse model of the disease (18, 19) . Predominance of pathology in the CNS emphasizes the importance of analyzing neural cells and neurons to elucidate pathophysiology. Intracellular vacuoles with characteristics of lysosomes in brain cells is the pathological hallmark of the disease. Studying these lesions in cortical neurons of the MPSIIIB mouse, we showed that they were associated with Golgi complex alterations and modified expression of the Golgi matrix protein GM130 (20) , a tethering protein important for Golgi structure and dynamics (21) . We did not observe disorders of endocytosis or macro-autophagy in these cells.
The re-programmation of human skin fibroblasts into induced pluripotent stem cells (iPSc) and their subsequent differentiation in neural progenitors and neurons provide access to human neurons, the cell type most relevant to clinical expression of MPSIIIB in children. Reprogramming of MPSIIIB patient fibroblasts was efficient. However, the proliferation of emerging iPSc was impaired unless the enzyme defect was complemented by an exogenous enzyme. Patient undifferentiated iPSc and neurons expressed cell disorders, which were not observed in parental skin fibroblasts and in floating neurospheres. These defects may affect neurological development in young children.
RESULTS

Complementation of enzymatic defect allows isolation of patient iPSc
Skin fibroblast primary cultures were established from two MPSIIIB patients for diagnosis purpose. Patient 1 was homozygous for a previously undescribed splice donor mutation in the NAGLU gene (c.531+1G.C). Patient 2 was homozygous for p.R482W mutation in exon 6 (22) . NAGLU activity was below the detection threshold in cultured fibroblast extracts (0.04 + 0.01 and 0.03 + 0.02 mkat/kg, respectively, versus 1.23 + 0.02 mkat/kg in controls).
Cultured fibroblasts were exposed to retroviral vectors encoding OCT4, SOX2, KLF4 (control and patient 2), or to these three vectors combined with a vector coding for c-MYC (control and patient 1). After exposure, fibroblasts were grown on a feeder layer of irradiated mouse embryonic fibroblasts (iMEF) in the presence of basic fibroblast growth factor (FGF2, 10 ng/ml). Emerging iPSc-like clones positive for alkaline phosphatase (AP) were visible after 3 -4 weeks. Equivalent clone numbers were scored in control and MPSIIIB fibroblasts ( 0.1% of plated fibroblasts with the four vectors, 0.01% without c-MYC vector).
Control iPSc-like clones rapidly expanded (cloning efficiency 87.5%, n ¼ 24). In contrast, patient iPSc-like clones poorly proliferated and were inefficiently cloned (cloning efficiency 2.5%, n ¼ 120; Supplementary Material, Fig. S1 ). Since FGFs act in concert with HS proteoglycans to activate FGF receptors (23) and partially digested HS accumulates in MPSIIIB cells, we assumed that impaired proliferation of emerging patient iPSc resulted from altered FGF2 signaling caused by HS. We therefore isolated patient iPSc-like clones in the presence of exogenous NAGLU to clear HS (24) . For that purpose, genetically engineered iMEF (NAGLU-iMEF) releasing NAGLU enzyme in culture supernatant were isolated. When grown on this feeder, patient iPSc-like clones rapidly expanded and were as efficiently cloned as control iPSc (cloning efficiency 83.3%, n ¼ 12; Supplementary Material, Fig. S1 ).
Characterization of iPSc clones
iPSc clones from control (C1, C2, C3), patient 1 (P1.1, P1.2, P1.3) and patient 2 (P2.1, P2.2, P2.3) were propagated for at least 20 passages on iMEF (control), or NAGLU-iMEF (patients). They showed normal karyotypes at passages 15-20 (data not shown). Mutations in the NAGLU gene were retrieved in patient clones. Cells expressed markers of pluripotency (SSEA4, TRA1-60, NANOG, Fig. 1A ). Quantitative PCR with reverse transcription (qRT-PCR) indicated efficient repression of exogenously introduced genes (Fig. 1B) . Endogenous pluripotency-associated genes were re-activated (Fig. 1C) . Whereas the OCT4 promoter was heavily methylated in parent fibroblasts, it was demethylated in iPSc clones, consistent with epigenetic reprogramming to pluripotency (Fig. 1D) . Six weeks after transplantation in immunodeficient mice, all control or patient iPSc formed teratoma. Histological examination revealed tissues from the three embryonic germ layers (Fig. 1E) . Thus, all control and patient iPSc clones were defined as human pluripotent iPSc.
Storage lesions are prominent in undifferentiated patient iPSc clones
Since exogenous NAGLU prevents expression of diseaserelated features, patient 1 and patient 2 iPSc clones were starved from the NAGLU enzyme after 15-20 passages. After transfer of patient iPSc clones to Matrigel TM -coated wells in the presence of FGF2 (100 ng/ml) for 10 days, NAGLU catalytic activity was undetectable and cells were intensely stained with anti-HS antibodies ( Fig. 2A) .
Patient 1 and patient 2 undifferentiated iPSc clones accumulated vacuoles positive for the lysosome-associated membrane
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Human Molecular Genetics, 2011, Vol. 20, No. 18 protein 1 (LAMP1) (Fig. 2B ) and these vacuoles were highly distended (1.50 + 0.17 mm 2 in patient iPSc, n ¼ 97, versus 0.065 + 0.04 mm 2 in controls, n ¼ 88, P ¼ 0.02). Electron microscopy revealed large vesicles with heterogeneous contents (Fig. 2D) . Western blot showed higher amounts of LAMP1 in patient than in control iPSc clones (Fig. 3A) , whereas LAMP1 mRNA levels were equivalent (data not shown). Additional disorders consisted of Golgi alterations in both patients' iPSc clones with modified GM130 staining patterns (Fig. 2B ) and co-staining of LAMP1-positive distended vesicles with anti-GM130 antibodies (Fig. 2C) . Intense GM130 staining and expression in patient iPSc clones (Figs 2B and F and 3B) suggested increased Golgi size or GM130 reactivity outside Golgi. Moreover, Golgi structure was disorganized, consisting of fragmented ribbons, accumulating small vesicles and apposition of storage vesicles to Golgi cisterna rims (Fig. 2E) . However, the vesicularization of Golgi stacks during mitosis was not affected in patients' iPSc (Supplementary Material, Fig S2A) . Both patients showed similar defects. Taken together, these results showed that undifferentiated patient iPSc exhibited prominent cell pathology. In contrast, cell pathology was absent in parental patient skin fibroblasts despite HS accumulation ( Fig. 2A) . LAMP1 and GM130 expressions were comparable with control fibroblasts, and Golgi complexes showed similar morphology (Supplementary Material, Fig. S3 ).
Patient iPSc clones are pluripotent iPSc differentiation can be examined in vitro by preventing cell adhesion, which results in the formation of embryoid bodies (EBs). After 10 days of non-adherent growth, Figure 1 . All control and patient iPSc clones exhibit human embryonic stem cell characteristics. (A) Representative images of iPSc clones emerging from control and patient fibroblasts growing on iMEF or NAGLU-iMEF feeder cells, respectively, are shown. Phase contrast views, AP staining, immunostaining for the pluripotency markers SSEA4, TRA-1-60 and NANOG and absence of staining for the differentiation factor SSEA1 are shown. Scale bars: 100 mm, except AP: 300 mm. (B) qRT-PCR shows that retroviral vector genomes coding for OCT4, KLF4, SOX2 and c-MYC mRNAs were silenced in iPSc clones (black bars), compared with parent human fibroblasts exposed to these vectors (T-hFib, white columns, value set to 1). Low persistent expression was detected in some clones, as reported by others (60) . (C) RT-PCR shows that iPSc clones but not parent fibroblasts (hFib-C, hFib-P1, hFib-P2) expressed mRNAs coding for endogenous genes related to pluripotency. The iPS(IMR90)-4 cell clone was taken as a reference (56) . GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was an internal control for mRNA detection. (D) Bisulfite sequencing was used to detect methylation on cloned PCR products from DNA of iPSc clones (C3, P1.3, P2.2), parent fibroblasts (hFib-C, hFib-P1, hFib-P2) or the reference iPS(IMR90)-4 clone. Circles correspond to five methylation sites (columns) on the OCT4 gene promoter sequence (open, unmethylated; filled, methylated) (61) . Ten PCR products (rows) from each cell line were analyzed. (E) All control and patient iPSc clones injected in Rag gC 2/2 mouse skeletal muscle formed teratomas. Pictures show representative images of structures identified after 6 weeks including neural tissues (ectoderm), gut-like epithelial tissues (endoderm) and bone and cartilage (ectoderm). Hematoxylin and eosin staining, scale bar: 50 mm. Electron microscopy examination of ultra-thin sections performed on neurosphere pellets revealed rare storage vacuoles, and although Golgi alterations were present, they were infrequent and milder than in undifferentiated iPSc (Fig. 5E ).
Human Molecular
With the aim to determine whether undegraded HS modify biological functions even in the absence of major visible cell pathology, we compared gene expression profiles between cells that did or did not accumulate HS. Total RNA was extracted from patient 2 parental fibroblasts before and after genetic correction of the enzyme defect, and from iPSc-derived neurosphere cultures (two controls, C1 and C3, and three patients, P1.1, P1.3, P2.3). Although only 50 mRNAs showed different levels in corrected and deficient fibroblasts (among 47 000 transcripts), NAGLU deficiency was associated with the modification of 3280 mRNAs (among 29 000 transcripts) in patient neural stem cells (microarray raw data available at http://www.ebi.ac.uk/arrayexpress/ E-MEXP-3033 and http ://www.ncbi.nlm.nih.gov/geo/ GSE23075). Genes with modified expression overlapped between the two cell types (23 out of the 50 modified fibroblast transcripts, Supplementary Material, Table S1 ). They pointed to modifications of extracellular matrix (ECM) constituents (synthesis of HS chains, fibronectin, tenascin, thrombospondin, elastin, collagens III and XI, nidogen and laminin gamma, proteases and proteases inhibitor involved in matrix turnover), molecules involved in cell -matrix interactions (integrins, FGFs, FGF receptors, semaphorins, ephrin, ephrin receptor, Slit), cell adhesion (calpain, protein kinase Cb, PDK1, phosphatidylinositol 3 kinase, tensin, parvin, RhoGTPases activating proteins, guanine exchange factors and Cdc42 effectors) and pathways transducing extra-cellular signals (PAK1, mitogen-activated kinases, c-fos, c-jun, phospholipase A2). Several constituents of the TGFb and wnt signaling pathways were also modified. Predicted functional consequences focus on cell communication (P-value 8 × 10 ). Expression levels of genes encoding proteins associated with lysosomes or the Golgi were modified in patients' neural stem cells but not in patients' fibroblasts (Supplementary Material, Table S2 ). With the exception of DRAM (damage-regulated autophagy modulator, P-value 2 × 10 23 ) and CD1d (10 22 ), all genes encoding proteins associated with lysosomes (26) were downregulated in patient cells, including lysosomal hydrolases, proton pumps, transmembrane transporters and other lysosomal membrane proteins. With the exception of GOLM1 (Golgi membrane protein 1, P-value 2 × 10 23 ), genes associated with Golgi morphology, localization and trafficking were downregulated.
Patient neurons show severe storage lesions and Golgi complex alterations
We next examined neural cell defects after adhesion of patient floating neurospheres. The differentiation of cells growing as floating neurospheres was induced by dissociation and adhesion on polyornithine -laminin-coated cover slips. Control and patient cultures contained equivalent proportions of b3-tubulin-positive differentiated neurons (40.6 + 7.6%, n ¼ 328, and 38 + 7.3%, n ¼ 339, after 3 weeks, respectively, Fig. 6A ), equivalent proportions of GABAergic neurons (15.6 + 4.2%, n ¼ 275, and 12.3 + 2.4%, n ¼ 224, of the MAP2-positive neuron population after 5 weeks, respectively, (Fig. 6A ). Both patient neurons contained abundant distended LAMP1-positive vacuoles (Fig. 7A) . Vacuole ultra-structure morphologies ( Fig. 6D ; Supplementary Material, S7) were reminiscent of those seen in undifferentiated patient iPSc (Fig. 2D) . These storage vesicles were positive for LAMP1 and for the ganglioside GM3. The secondary accumulation if this glycosphingolipid is typical of MPSIII (Supplementary Material, Fig. S8 ). Western blot and staining showed increased LAMP1 and GM130 signals, compared with controls (Figs 3E and F and 7B). LAMP1-distended vesicles were co-stained with GM130 (Fig. 7C) , and GM130 staining was more intense and broader with frequent extensions in neurites (Fig. 7D ). Patient cells with neuronal morphology contained numerous abnormal Golgi complexes (Fig. 7E ). Golgi complexes with disorganized morphology (51.2% in patients and 6.2% in controls) typically consisted of multiple short stacks that were not linked and often not aligned with respect to each other, associated with the accumulation of small vesicles. Storage vacuoles were frequently apposed at, or even connected to, the rims of fragmented ribbons. However, dysmorphic Golgi complexes collapsed in response to brefeldin A as efficiently as Golgi complexes in control cells, suggesting efficient vesicular trafficking in pre-Golgi compartments (Supplementary Material,  Fig. S2B ). These observations indicated prominent cell pathology in MPSIIIB human neurons.
DISCUSSION
We demonstrate that iPSc can be generated from the fibroblasts of children with MPSIIIB, a fatal LSD with major CNS involvement. NAGLU deficiency affected the proliferation of emerging iPSc clones, necessitating compensation of the genetic defect through enzyme replacement for efficient isolation. In contrast with parental patient fibroblasts, isolated iPSc rapidly exhibited prominent cell pathology once exogenous enzyme supply was halted. Disease expression did not 
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impair iPSc survival and differentiation, allowing efficient isolation of affected neural stem cells and differentiated neurons. Whereas cell pathology was modest in floating neurosphere cultures, gene expression profiling revealed changes affecting multiple pathways, consistent with alterations of cell interactions with the environment. Neural stem cell adhesion and differentiation were accompanied by the installation of severe cell pathology consisting of intracellular vacuoles and severe disorganization of Golgi complex structure. The examination of patients' pluripotent stem cells and their neural and neuronal progenies revealed for the first time the existence of Golgi defects in a lysosomal disorder. Patient iPSc required compensation of or adaptation to enzyme deficiency for proliferation. Fibroblast reprogrammation led to the emergence of iPSc clones with equal frequencies in patient and control fibroblasts. However, whereas clones emerging from normal fibroblasts rapidly proliferated in the presence of FGF2, emerging patient iPSc did not, suggesting inefficient response to this factor. This phenotype was reversed when feeder cells supplied the missing lysosomal enzyme. Enzyme replacement is currently a routine treatment for several MPSs (27) . The exogenous enzyme clears GAGs, including HS, which accumulate as a consequence of the enzyme defect. HS proteoglycans act in concert with FGFs to transduce cell proliferation signals (23) . In MPSs, the accumulation of partially degraded HS affects FGF2 signaling (28) , as shown by impaired proliferation and survival of multipotent hematopoietic progenitors in MPSI mice (29) , or inefficient FGF2-dependent neurogenesis and reduced FGF1, FGF2 and FGF1 receptor mRNA expression in MPSIIIB mice (12) . Reversion of the proliferation defect of MPSIIIB patient iPSc after exogenous enzyme supply suggested that impaired FGF signaling was due to the accumulation of partially degraded HS. Impaired FGF signaling affects major biological functions in pluripotent stem cells, including self-renewal, proliferation, survival, differentiation and adhesion (30) .
Enzyme replacement is sufficient to prevent pathology in mucopolysaccharidoses, indicating that partially degraded proteoglycans induce disorders. Once patient iPSc had been established in the presence of NAGLU exogenous enzyme, they could be starved from this supply. Enzyme-starved iPSc, as well as their progenies, rapidly accumulated HS proteoglycans. They nevertheless survived and efficiently proliferated, suggesting that efficient response to FGF2, and possibly to other undefined growth-survival factors, was now achieved despite HS accumulation. This observation is important as it indicates that modified biological functions identified in chronically deficient MPSIIIB cells may result from adaptive processes turned on to survive HS proteoglycan degradation defect.
Post-mortem studies of affected patient tissues (15, 17) as well as pathology studies in MPSIIIB mice (18, 19) showed predominant storage lesions in brain cells. These observations are consistent with the clinical expression of the disease, which predominates in the CNS. They are also consistent with mild or absent disease-related phenotype in patient skin fibroblasts, despite significant HS accumulation. Examination of human iPS-derived neurons, the cell type most relevant to clinical manifestation, therefore appears the best approach to investigate human MPSIIIB cell pathology. We show that patient iPSc provided suitable models for this purpose, exhibiting disorders that were not apparent in parental fibroblasts. The neuronal progeny of these cells also expressed disorders, suggesting that similar pathological processes affected pluripotent stem cells and neurons. These results are remarkable as there are currently very few neuronal disorders in which disease-related phenotype was documented in patient iPSc and/or their progeny (31) (32) (33) (34) . Cell disorders in patient iPSc and neurons consist of intracellular storage vesicles, the hallmark of cell alterations in MPSIIIB. Vacuoles were associated and frequently apposed to major alterations of Golgi structure. Golgi complexes consisted of multiple short stacks that were not linked and often not aligned with respect to each other. Golgi defects were not associated with altered cell survival or differentiation. They were compatible with efficient vesicularization during mitosis or Golgi collapse in response to brefeldin A. Previous studies indicated that Golgi alterations induced by the depletion of GM130, a Golgi matrix protein necessary for proper cisternae stacking, do not affect transport kinetics in the secretory pathway (35) . They may nevertheless be associated with defective glycoprotein sialylation (36) of glycosphingolipid synthesis (37) . The secondary accumulation of GM3 gangliosides, which is associated with several MPS (10), might be related to Golgi structural alterations.
The Golgi phenotype is highly reminiscent of cells acutely depleted of GM130 using siRNAs (35, 36) . Thus, cell pathology combined GM130 overexpression with features consistent with GM130 loss-of-function, suggesting that GM130 was at least partly not functional in patient iPSc and neurons. Since partner proteins of GM130 that are needed to perform biological functions, like GRAPS65 or p115, were not detected in GM130-positive storage vesicles analyzed in mouse neurons (20) , our hypothesis was that GM130 is stuck in a position that impairs appropriate interaction with its partners. GM130 functions are not limited to the formation of tethering complexes necessary for incorporation of pre-Golgi carriers into stacks, which ensures the maintenance of Golgi architecture (35, 36) . They also comprise control of microtubule nucleation at the Golgi surface (38) and Cdc42-mediated determination of cell polarity through interaction with the Cdc42 guanine exchange factor Tuba (39, 40) . Partial loss of GM130 function in human patient iPSc and neurons could therefore affect stem cell polarity, migration and motility and subsequently neurogenesis and neuritogenesis.
How are alterations observed in patient iPSc and their progeny related to HS accumulation? Although cell pathology was mild or absent in patient floating neurospheres or in parental fibroblasts, gene expression profiles revealed modified expression patterns relative to control cells in which HS did not accumulate. Most of the genes encoding constituents of the ECM were affected. Downregulation of HS2ST, HS6ST, HS3ST, the three enzymes responsible for the density and type of sulfation within HS saccharidic chains, suggested modified profiles of ligand sensitivities (41, 42) . Molecules involved in cell -matrix interactions were also modified, as well as downstream intracellular effectors associated with the mitogen-activated pathways, or the wnt and TGFb pathways. These results are evocative of functional alterations of cell -matrix interactions. HS proteoglycans are major determinants of how the cells sense environmental cues bound to ECM. As co-receptors for cell adhesion, cell proliferation and fate determination molecules and other extracellular signals, they collaborate with 'primary' receptors to control signaling. HS proteoglycans are endocytosed and fragmented into oligosaccharides by heparanases in early endosomes. In the absence of further degradation in lysosomes, as in NAGLU-deficient cells, oligosaccharides accumulate in intracellular compartments and are released in the environment, where they bind ECM proteins and modify the bioavailability of multiple signaling molecules. Changes in cell -matrix interactions resulting from this modified environment likely affect cell identification and responses to environmental cues important for adhesion, migration, process extension, polarization and fate specification (43) (44) (45) . Modified control of the extra-cellular signalregulated pathway, which is activated by FGFs and controls Golgi remodeling through the phosphorylation of GRASP65, might account for the observed disorganization of Golgi architecture (46) . Interestingly, mild expression of this phenotype in floating neurospheres may result from less stringent dependence of non-adherent cells on matrix-bound cues, compared with adherent iPSc or differentiating neural cells. Similarly, matrix-bound cues important for iPSc and neural cells may be largely irrelevant for fibroblasts.
Previous gene expression profiling studies in MPSIIIB mouse tissues showed upregulation of genes related to lysosomal functions and inflammation (47-49). We were surprised that genes coding for lysosomal proteins, or proteins carrying mannose-6-phosphate residues (26), were either unchanged in fibroblasts accumulating HS or downregulated in patient neural stem cells. These observations do not support the hypothesis that deficient lysosomal functions induced lysosomes proliferation (50) . In contrast, changes in the expression of genes related to Golgi functions in patient neural stem cells were consistent with the observed modifications of Golgi architecture.
Is MPSIIIB a developmental disease? Whereas cell defects identified in patient iPSc could impinge on their differentiation capacity, assays performed in several paradigms indicated that they behave like control iPSc, giving rise to differentiated cell progeny with similar efficiency, kinetics and pattern. These results appear consistent with the absence of clinical manifestations of the disease during fetal life and at birth in affected children (51, 52) and animal models (19, 53) . However, these observations are not sufficient to conclude that stem cells behave normally in MPSIIIB. Indeed, the teratoma formation assay, which showed normal patient iPSc differentiation, was performed in recipient mice that are able to complement the enzymatic defect of patient iPSc. In affected humans, the CNS is presumably protected against HS proteoglycan toxicity until birth through the delivery of a maternal enzyme across the blood -brain barrier, as suggested by blood -brain barrier permeability to mannose-6-phosphate bearing molecules until birth in mice (54) . Although EB formation and neural stem cell differentiation paradigms showed apparently normal behavior of patient iPSc in the absence of enzyme complementation, the accuracy of these in vitro assays is clearly not sufficient to detect subtle deviations from normal differentiation pattern, as they may occur in vivo. Considering the central role of matrix -cell interactions, cell migration, neurogenesis and neuritogenesis in post-natal CNS development, developmental damage may occur in MPSIIIB children. This possibility has major implications with regard to treatments aimed at restoring normal brain plasticity and cognition in affected children. Very early in life, reduction of HS burden is presumably the best situation for clinical success.
MATERIALS AND METHODS
iPSc generation and differentiation
Skin fibroblast cultures from two MPSIIIB patients and one non-affected volunteer were obtained from the Centre de Ressources Biologiques in Lyon (France) after approval by the competent authorities. A statement of biological samples was made according to French laws formulated by the Ministère de la Recherche et au Comité de Protection des Personnes Ile de France (reference DC-2009-1067). Fibroblasts were grown in DMEM Glutamax (Invitrogen) supplemented with 10% fetal bovin serum (FBS) (Sigma). iPSc clones were generated as previously described (55) . Retrovirus plasmids carrying human cDNA coding for OCT4, SOX2, KLF4 and c-MYC were used (Addgene plasmids 17217, 17218, 17219, 17220). After VSV-G-pseudotyped retrovirus vector production, 5 × 10 4 cells for MPSIIIB fibroblasts and 10 5 cells for control fibroblasts were transduced twice with the retrovirus vectors in the presence of sulfate protamine (5 mg/ml, Sigma). Clones with welldefined hES-like morphology were observed 3 weeks after gene transfer. They were selected and manually picked 1 or 2 weeks later. iPSc clones were maintained on iMEF feeder layers in the following medium (iPSc medium): DMEM/F12 (Invitrogen) containing 20% KnockOut Serum Replacement (Invitrogen), 10 ng/ml of FGF2 (Miltenyi Biotech, Paris, France), 100 mM nonessential amino acids (Invitrogen) and 100 mM 2-mercaptoethanol (Invitrogen). Cultures were passaged every 5-10 days either manually or enzymatically with collagenase type IV (1 mg/ml) (Invitrogen). MPSIIIB iPSc clones were isolated and cultured on iMEF transduced with a lentivirus vector encoding human NAGLU (NAGLU-iMEF) (11) . NAGLU activities in cell supernatants were increased 4.3-fold in transduced cells. To culture iPSc clones without iMEF, iPSc clones were transferred onto Matrigel TM -coated wells (BD Biosciences) in mTeSR TM 1 medium (Stem Cell Technologies). iPSc clones were passaged either manually or enzymatically with dispase (2 mg/ml, Invitrogen). The iPS(IMR90)-4 cell clone (56) (WiCell Research Institute Madison, WA, USA) was also cultured on Matrigel TM -coated wells in mTeSR TM 1 medium. For EB differentiation, iPSc clones were collected as small clusters after collagenase treatment. Clusters were resuspended in iPSc medium without FGF2. Ten days later, EBs were plated on polyornithine (20 mg/ml) and laminin (10 mg/ ml)-coated cover slips and incubated for 8 additional days. For neural differentiation, neurospheres were generated as previously described (31) . To induce neural differentiation, neurospheres were dissociated into single-cell suspension with Accumax (PAA Laboratories, Linz, Austria) and 2 × 10 5 cells were plated onto polyornithine -laminin-coated cover slips in DMEM/F12 supplemented with 2% B27 (Invitrogen). To quantify plating efficiencies, cells were fixed with 4% 
Flow cytometry analysis and apoptosis
Cells were fixed in 2% PFA and incubated for 1 h either with an anti-GM130 antibody (1:100) or with an isotypic mAb as a negative control in PBS containing 1% fetal calf serum. Secondary antibody used was an Alexa488 anti-mouse IgG1 (Invitrogen). Apoptosis was analyzed with the Vybrant Apoptosis Assay Kit (Invitrogen) according to the manufacturer's protocol.
GAG dosage
Neurospheres were collected by centrifugation and overnight lysed in acetate buffer (100 mM sodium acetate, pH 5, containing 5 mM cystein, 5 mM EDTA) supplemented with papain 3% (Sigma) at 658C. After centrifugation, sulfated GAGs were quantified in supernatants with the Blyscan Sulfated Glycosaminoglycan Assay (Biocolor) according to the manufacturer's protocol.
Electron microscopy
Cells were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer and post-fixed with 1% osmium tetroxide for 1 h. Cells were then dehydrated through increasing ethanol baths, and embedded in Epon 812. Ultra-thin sections (70 nm) were prepared using a Reichert Ultracut S Wild M3z microtome (Leica) and contrasted with uranyl acetate and lead citrate. Ultra-structural analyses were performed on a JEOL 1200EXII transmission electron microscope (JEOL) equipped with an Eloise Megaview camera controlled by the Analysis Pro 3.1 software (Eloise).
MPSIIIB genotyping and karyotyping
Genotyping of MPSIIIB mutations was performed by PCR amplification and sequencing of genomic DNA (Supplementary Material, Table S3 ). Karyotyping was performed by Pasteur-Cerba (Cergy-Pontoise, France). Analyses were performed on the following clones: C2 (passage 8), C3 (passage 21), P1.1 (passage 10), P1.3 (passage 16), P2.2 (passage 16), P2.3 (passage 8).
RT-PCR and qRT-PCR
Total RNA was extracted using TRIzol (Invitrogen) and treated with TurboDNAse (Applied Biosystems). One microgram of total RNA was used to synthesize cDNA with hexanucleotide random primers pdN6 and MMLV reverse transcriptase (Superscript II, Invitrogen). RT-PCR was performed in a thermocycler (Eppendorf) with 50 ng of cDNA Table S3 ) was done using the Primer Express software.
Bisulfite sequencing
Genomic DNA was treated with EpiTech Bisulfite according to the manufacturer's recommendations (Qiagen). The promoter region of the human OCT4 gene was amplified by PCR. The PCR products were subcloned into pCR2-TOPO (Invitrogen). Ten clones of each sample were verified by sequencing (Eurofins MWG Operon). Primers' 'bisulfite sequencing' are listed in Supplementary Material, Table S3 .
Teratoma formation
Approximately 2 × 10 6 dissociated iPSc were injected intramuscularly in Rag gC 2/2 mice. Six weeks after injection, teratomas were dissected, fixed in 10% formalin and embedded in paraffin. Sections were stained with hematoxylin and eosin.
Affymetrix exon array hybridization and data analysis
Fibroblasts from patient 2 were exposed to lentivirus vectors coding for GFP (HS+), or to two vectors coding for GFP and NAGLU, respectively (HS2). GFP expression and NAGLU activity were verified in three independent cultures of each type, from which 100 ng of total RNA was isolated, providing three independent samples for each condition. After amplification and labeling with Affymetrix reagents, targets were hybridized to Affymetrix Human Genome U-133 Plus 2.0 chips (47 000 transcripts, 38 500 genes). For neural stem cells, 100 ng of total RNA from C1, C3, P1.1, P1.3 and P2.3 neurospheres were amplified, labeled with Affymetrix reagents and hybridized to Affymetrix-GeneChip Human Exon 1.0 ST arrays. Affymetrix Exon Array data analyses were performed using EASANA from GenoSplice (GenoSplice Technology) (57) . For analyses, a third synthetic sample (C1 -3) was generated from the two control arrays C1 and C3 to artificially increase the number of reference samples and in order to increase statistical power of results (58) . Unpaired statistical analyses were performed using Student's t-test as previously described (59). Taking into account probe expression level and probe quality such as cross-hybridization, repeat region and number of GC-rich regions, 11 505 genes were analyzed. Results were considered statistically significant for P ≤ 0.05 and fold changes ≥1.2.
Statistical analyses
Statistics were performed using the SPSS software (SPSS).
